SGYPW Profile
Synergy Pharmaceuticals, Inc. (SGYPW) is a former stock symbol for Synergy Pharmaceuticals, a biopharmaceutical company focused on the development of novel therapies for the treatment of gastrointestinal diseases and disorders. The company was headquartered in New York, NY and was listed on the NASDAQ exchange.
In December 2019, the company filed for voluntary Chapter 11 bankruptcy and its assets were acquired by Bausch Health Companies Inc. for $200 million. As part of the bankruptcy proceedings, the company's common stock was cancelled and no longer trades on any public exchange.
Investors who held shares of SGYPW were likely impacted by the bankruptcy and may have received a payout from the liquidation of the company's assets. As with any investment, investors should carefully consider the risks and potential rewards of investing in a company before making a decision to buy or sell shares.
|
